M.C. Cau

445 total citations
15 papers, 286 citations indexed

About

M.C. Cau is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M.C. Cau has authored 15 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in M.C. Cau's work include Head and Neck Cancer Studies (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Nutrition and Health in Aging (3 papers). M.C. Cau is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Nutrition and Health in Aging (3 papers). M.C. Cau collaborates with scholars based in Italy, Germany and France. M.C. Cau's co-authors include Antonio Macciò, Giovanni Mantovani, Clelia Madeddu, Filomena Panzone, Giulia Gramignano, C. Floris, Carlo Mulas, Giorgia Antoni, Roberto Serpe and Francesca Maria Tanca and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M.C. Cau

15 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Cau Italy 6 167 70 65 50 44 15 286
Francesca Maria Tanca Italy 6 199 1.2× 46 0.7× 87 1.3× 46 0.9× 19 0.4× 10 273
Yiwei Zhu China 6 200 1.2× 41 0.6× 35 0.5× 77 1.5× 61 1.4× 20 356
G. Amyotte Canada 4 132 0.8× 83 1.2× 30 0.5× 70 1.4× 56 1.3× 4 289
Jiaan Hu China 9 116 0.7× 47 0.7× 66 1.0× 7 0.1× 19 0.4× 19 273
E.B. Haverkort Netherlands 10 233 1.4× 162 2.3× 114 1.8× 34 0.7× 183 4.2× 12 488
Giovanni Imbimbo Italy 10 161 1.0× 42 0.6× 57 0.9× 30 0.6× 26 0.6× 31 259
Fan‐Feng Chen China 8 211 1.3× 81 1.2× 43 0.7× 30 0.6× 187 4.3× 18 388
Thomas Kung Germany 8 163 1.0× 40 0.6× 59 0.9× 11 0.2× 41 0.9× 12 343
Tianpeng Xie China 11 39 0.2× 80 1.1× 47 0.7× 29 0.6× 157 3.6× 42 407

Countries citing papers authored by M.C. Cau

Since Specialization
Citations

This map shows the geographic impact of M.C. Cau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Cau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Cau more than expected).

Fields of papers citing papers by M.C. Cau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Cau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Cau. The network helps show where M.C. Cau may publish in the future.

Co-authorship network of co-authors of M.C. Cau

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Cau. A scholar is included among the top collaborators of M.C. Cau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Cau. M.C. Cau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cavalieri, Stefano, Ester Orlandi, Cristiana Bergamini, et al.. (2025). Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real‐World Data From 17 Italian Centers. Head & Neck. 47(7). 2040–2047. 2 indexed citations
2.
Tourneau, Christophe Le, Massimo Ghiani, M.C. Cau, et al.. (2023). First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE. Cancer Reports. 6(5). e1804–e1804. 4 indexed citations
3.
Bossi, Paolo, Alessandro Esposito, Stefania Vecchio, et al.. (2021). 864MO Role of geriatric assessment in tailoring treatment of locally advanced head and neck cancer: The ELDERLY study. Annals of Oncology. 32. S789–S789. 5 indexed citations
4.
Cavalieri, Stefano, Luigi Mariani, Vincent Vander Poorten, et al.. (2020). Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands. European Journal of Cancer. 136. 35–42. 25 indexed citations
5.
6.
7.
Siano, Marco, Gabriele Infante, Carlo Resteghini, et al.. (2017). Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy. Oral Oncology. 69. 33–37. 13 indexed citations
8.
9.
Locati, Laura D., Loris De Cecco, Federica Perrone, et al.. (2015). Upregulation of RAS pathway to predict the risk of distant metastases in HPV + oropharynx cancer.. Journal of Clinical Oncology. 33(15_suppl). e17073–e17073. 1 indexed citations
10.
Serpe, Roberto, Clelia Madeddu, Filomena Panzone, et al.. (2012). Krill oil to improve blood lipids status in advanced cancer patient with cachexia.. Journal of Clinical Oncology. 30(15_suppl). e19634–e19634. 1 indexed citations
11.
Madeddu, Clelia, M.C. Cau, Filomena Panzone, et al.. (2012). Efficacy and Safety of a Two Drug-Combination Regimen for Cancer-Related Cachexia in the Clinical Practice. Annals of Oncology. 23. ix462–ix462. 1 indexed citations
12.
Mantovani, G., Clelia Madeddu, Filomena Panzone, et al.. (2012). Curcuma Longa Extract is Effective in Improving Inflammatory Status and Redox Balance in Patients with Cancer-Related Cachexia and Oxidative Stress. Annals of Oncology. 23. ix463–ix463. 3 indexed citations
13.
Macciò, Antonio, Clelia Madeddu, Giulia Gramignano, et al.. (2011). A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecologic Oncology. 124(3). 417–425. 102 indexed citations
14.
Madeddu, Clelia, Mariele Dessì, Filomena Panzone, et al.. (2011). Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clinical Nutrition. 31(2). 176–182. 95 indexed citations
15.
Cau, M.C., et al.. (1983). Diclofenac Sodium in Ureteral Colic: A Double-Blind Comparison Trial with Placebo. Journal of International Medical Research. 11(5). 303–307. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Maria Tanca Breakdown of academic impact, for papers by Yiwei Zhu Breakdown of academic impact, for papers by G. Amyotte Breakdown of academic impact, for papers by Jiaan Hu Breakdown of academic impact, for papers by E.B. Haverkort Breakdown of academic impact, for papers by Giovanni Imbimbo Breakdown of academic impact, for papers by Fan‐Feng Chen Breakdown of academic impact, for papers by Thomas Kung Breakdown of academic impact, for papers by Tianpeng Xie
Rankless by CCL
2026